These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 1456087

  • 1. Prostaglandin E2 alleviates cyclosporin A-induced bone loss in the rat.
    Katz IA, Jee WS, Joffe II, Stein B, Takizawa M, Jacobs TW, Setterberg R, Lin BY, Tang LY, Ke HZ.
    J Bone Miner Res; 1992 Oct; 7(10):1191-200. PubMed ID: 1456087
    [Abstract] [Full Text] [Related]

  • 2. Effect of cyclosporin A on bone mineral metabolism in experimental diabetes mellitus in the rat.
    Epstein S, Takizawa M, Stein B, Katz IA, Joffe II, Romero DF, Liang XG, Li M, Ke HZ, Jee WS.
    J Bone Miner Res; 1994 Apr; 9(4):557-66. PubMed ID: 8030444
    [Abstract] [Full Text] [Related]

  • 3. Influence of age on cyclosporin A-induced alterations in bone mineral metabolism in the rat in vivo.
    Katz I, Li M, Joffe I, Stein B, Jacobs T, Liang XG, Ke HZ, Jee W, Epstein S.
    J Bone Miner Res; 1994 Jan; 9(1):59-67. PubMed ID: 8154310
    [Abstract] [Full Text] [Related]

  • 4. Raloxifene analog (LY117018 HCL) ameliorates cyclosporin A-induced osteopenia in oophorectomized rats.
    Bowman AR, Sass DA, Marshall I, Ma YF, Liang H, Jee WS, Epstein S.
    J Bone Miner Res; 1996 Aug; 11(8):1191-8. PubMed ID: 8854256
    [Abstract] [Full Text] [Related]

  • 5. The bisphosphonate 2-PEBP inhibits cyclosporin A induced high-turnover osteopenia in the rat.
    Movsowitz C, Epstein S, Fallon M, Ismail F, Thomas S.
    J Lab Clin Med; 1990 Jan; 115(1):62-8. PubMed ID: 2299257
    [Abstract] [Full Text] [Related]

  • 6. Effect of the interaction of parathyroid hormone and cyclosporine a on bone mineral metabolism in the rat.
    Epstein S, Dissanayake IR, Goodman GR, Bowman AR, Zhou H, Ma Y, Jee WS.
    Calcif Tissue Int; 2001 Apr; 68(4):240-7. PubMed ID: 11353952
    [Abstract] [Full Text] [Related]

  • 7. Azathioprine alone is bone sparing and does not alter cyclosporin A-induced osteopenia in the rat.
    Bryer HP, Isserow JA, Armstrong EC, Mann GN, Rucinski B, Buchinsky FJ, Romero DF, Epstein S.
    J Bone Miner Res; 1995 Jan; 10(1):132-8. PubMed ID: 7747620
    [Abstract] [Full Text] [Related]

  • 8. The role of testosterone in cyclosporine-induced osteopenia.
    Bowman AR, Sass DA, Dissanayake IR, Ma YF, Liang H, Yuan Z, Jee WS, Epstein S.
    J Bone Miner Res; 1997 Apr; 12(4):607-15. PubMed ID: 9101372
    [Abstract] [Full Text] [Related]

  • 9. Combined treatment with cyclosporin A and cortisone acetate minimizes the adverse bone effects of either agent alone.
    Movsowitz C, Schlosberg M, Epstein S, Ismail F, Fallon M, Thomas S.
    J Orthop Res; 1990 Sep; 8(5):635-41. PubMed ID: 2388102
    [Abstract] [Full Text] [Related]

  • 10. Interferon-gamma causes loss of bone volume in vivo and fails to ameliorate cyclosporin A-induced osteopenia.
    Mann GN, Jacobs TW, Buchinsky FJ, Armstrong EC, Li M, Ke HZ, Ma YF, Jee WS, Epstein S.
    Endocrinology; 1994 Sep; 135(3):1077-83. PubMed ID: 8070349
    [Abstract] [Full Text] [Related]

  • 11. 17 beta-estradiol prevents osteopenia in the oophorectomized rat treated with cyclosporin-A.
    Joffe I, Katz I, Jacobs T, Stein B, Takizawa M, Liu C, Berlin J, Epstein S.
    Endocrinology; 1992 Mar; 130(3):1578-86. PubMed ID: 1537307
    [Abstract] [Full Text] [Related]

  • 12. Cyclosporin A in the oophorectomized rat: unexpected severe bone resorption.
    Movsowitz C, Epstein S, Ismail F, Fallon M, Thomas S.
    J Bone Miner Res; 1989 Jun; 4(3):393-8. PubMed ID: 2788358
    [Abstract] [Full Text] [Related]

  • 13. Alendronate prevents cyclosporin A-induced osteopenia in the rat.
    Sass DA, Bowman AR, Yuan Z, Ma Y, Jee WS, Epstein S.
    Bone; 1997 Jul; 21(1):65-70. PubMed ID: 9213009
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Rapamycin: a bone sparing immunosuppressant?
    Romero DF, Buchinsky FJ, Rucinski B, Cvetkovic M, Bryer HP, Liang XG, Ma YF, Jee WS, Epstein S.
    J Bone Miner Res; 1995 May; 10(5):760-8. PubMed ID: 7543725
    [Abstract] [Full Text] [Related]

  • 16. Utilization of cyclosporine H to elucidate the possible mechanisms of cyclosporine A-induced osteopenia in the rat.
    Rucinski B, Liu CC, Epstein S.
    Metabolism; 1994 Sep; 43(9):1114-8. PubMed ID: 8084286
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Partial maintenance of extra cancellous bone mass by antiresorptive agents after discontinuation of human parathyroid hormone (1-38) in right hindlimb immobilized rats.
    Ma Y, Jee WS, Chen Y, Gasser J, Ke HZ, Li XJ, Kimmel DB.
    J Bone Miner Res; 1995 Nov; 10(11):1726-34. PubMed ID: 8592950
    [Abstract] [Full Text] [Related]

  • 19. Prostaglandin E2 administered by subcutaneous pellets causes local inflammation and systemic bone loss: a model for inflammation-induced bone disease.
    Desimone DP, Greene VS, Hannon KS, Turner RT, Bell NH.
    J Bone Miner Res; 1993 May; 8(5):625-34. PubMed ID: 8511990
    [Abstract] [Full Text] [Related]

  • 20. Prostaglandin E2 (PGE2) and risedronate was superior to PGE2 alone in maintaining newly added bone in the cortical bone site after withdrawal in older intact rats.
    Ma YF, Lin BY, Jee WS, Lin CH, Chen YY, Ke HZ, Li XJ.
    J Bone Miner Res; 1997 Feb; 12(2):267-75. PubMed ID: 9041060
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.